Sonabend, Adam M
- Northwestern University · Neurosurgery (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #12,258
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Neurosurgery
NIH Funding · FY2023
Linked Award Amount
$857.5K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#12,258
By linked amount among FY2023 PIs
Earliest Year Loaded
2015
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Sonabend, Adam M as a PI. Multi-PI records show the full award amount for context.
- 5R01CA245969-04R01Contact PIBlood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastomaNorthwestern University · Neurosurgery (NIH department code)$481.5Kaward amount
- 5R01NS110703-04R01Contact PIMAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapyNorthwestern University · Neurosurgery (NIH department code)$376Kaward amount
Award organization
Organizations that administered FY2023 awards listing Sonabend, Adam M as a PI.
FY2023 award administered by Northwestern University (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardNorthwestern University
- 2016$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017R01 Grant Holder
- 2021$2M Cumulative Funding